The near-uniform competence of Fz iso-
forms for Gpr124/Reck-dependent Wnt7a/b
signaling reveals that these ligands lose their
capacity to distinguish Fz receptors when
bound by Reck within the Gpr124/Reck/Fz/
Lrp5/6 complex. Because Wnt ligands discrim-
inate Fz receptors primarily via site 2 ( 15 ), we
suspected that Wnt7a/b activity at the BBB
might be dominated by site 1 of the N-terminal
domain (NTD). Supporting this hypothesis,
chimeric Wnt ligands composed of Wnt7a
NTD fused to a C-terminal domain (CTD)
derived from another Wnt were competent
for Reck binding and Gpr124/Reck-dependent
signaling (fig. S4) ( 19 , 21 ).
This suggested that in contrast to the sys-
temic“off-target”situation, where both con-
tact sites 1 and 2 are strictly required for Wnt
signaling, Wnt7a/b-Fz interaction at site 2
might become dispensable in the context of
Gpr124/Reck-stimulated signaling. Accord-
ingly, Wnt7aNTD, a hemisected Wnt7a variant,
retained partial activity on Gpr124/Reck/Fz1-
mediated signaling while showing no stimu-
lation of Fz5 signaling, used as a paradigm
“off-target”readout (Fig. 1B). Furthermore, mu-
tating three of the five Wnt7a residues involved
Martinet al.,Science 375 , eabm4459 (2022) 18 February 2022 2 of 11
Fig. 1. Engineering Wnt7a
ligands into highly specific
Gpr124/Reck activators.
(A) Backbone model of murine
Wnt7a based on the crystal
structure of XWnt8a ( 15 ) and
schematics of the receptor
complexes mediating
Wnt7a/b/b-catenin signaling.
(B) Relative STF (super
top flash) luciferase activity of
Wnt7a and its depicted var-
iants on Fz5 or Gpr124/Reck/
Fz1. (C) Position and color-coded
Gpr124/Reck/Fz1 or Fz5 STF
activities of 147 V5-tagged
single-residue Wnt7a variants.
Gpr124/Reck agonists (blue
dots) were defined as variants
with >70% Gpr124/Reck/Fz1
and <10% Fz5 activity. (D) Front,
lateral, and back views of the
Wnt7a surface model with
integrated color-coded activities
of all 147 single-residue
variants. Agonists are in blue.
(E)b-Catenin signaling assays
using STF cells transfected with
any of the 10 Fz receptors or
Gpr124/Reck, together with
Wnt7a, Wnt7aNTD, Wnt7aK190A,
or the empty pCS2 vector.
(F) Phenotypic scoring of stage
36 Xenopus laevisembryos
injected into the ventral vegetal
region of the four-cell embryo
with 15 pg of the indicated
mRNA. Arrowhead indicates
duplicated axis. (G) Phenotypic
scoring of 3-dpf zebrafish larvae
injected at the one-cell stage
with Wnt7a, Wnt7aNTD, or
Wnt7aK190AmRNA at the indi-
cated doses. Colored arrow-
heads refer to the phenotypic
classes on the right. Wnt7a and
variants are V5-tagged. Data
are means ± SD. ***P< 0.001.
Amino acid abbreviations: A, Ala;
E, Glu; F, Phe; I, Ile; K, Lys;
L, Leu; M, Met; P, Pro; R, Arg;
T, Thr; V, Val; W, Trp; Y, Tyr.
E
Relative luciferase activity
1
1.5
0.5
2
2.5
3
0
Wnt7a Wnt7aNTD Wnt7aK190A pCS2
Fz1
Fz2
Fz3
Fz4
Fz5
Fz6
Fz7
Fz8
Fz9
Fz10
Gpr124/Reck
pCS2
***
***
***
***
***
0 50 1000 50 1000 50 100
Fz5 Gpr124/Reck/Fz1
Relative^050100
luciferase
activity
(%)
***
Wnt7a Wnt7aS206A Wnt7aNTD Wnt7aCTD
NTD
ThumbSite1
Linker
domain CTD
PalmitoleicS206 S206A
acid
Site2Index
Wnt7a
NTD
Site1
Thumb
Linker
domain CTD
PalmitoleicS206
acid
Site2
Index
A
W322A
T266A
K229A
K231AV236A
K190A
K212A
I160A
K164A
V99AE239AY260A
P263A
F75A
Fz, Lrp5/6, Gpr124, Reck
Fz (site 1/2)+Lrp5/6
High (Wnt7a, Wnt7b)
Limited
+Reck
p p
Gpr124
Reck domainLinker
Fz, Lrp5/6
Fz (site 1/2)+Lrp5/6
Limited
Fz5, Fz8
Frizzled
(Fz)
Lrp5/6
p
systemic
"off-target"
BBB
"on-target"
Receptor complex
Wnt7 contacts
Wnt specificity
Frizzled specificity
Wnt7a/b
B
Wnt7a
F
G
51
11011021031101102103 RNA (pg)
56 23 67 40 9373 80 52 39 40
343843
29 98 99
Phenotype class (%)
Wnt7a Wnt7aNTDWnt7aK190A
Wnt7aWnt7a
NTD
1101102103
n= 43 36 98 50514145
20
0
40
60
80
100
Phenotype class (%)
n=
20
0
40
60
80
100
unaffected
eyeless
dysmorphic
unaffected
duplicated
axis
Wnt7a
Wnt7aNTD
Wnt7aK190A
Wnt7a Wnt7aNTD Wnt7aK190A
1 pg
10 pg
100 pg
1 pg
10 pg
100 pg
10 pg
100 pg
1 pg
Wnt7a
K190A
K190A
K273A
K95AK296A
K255A
CD
Gpr124/Reck/Fz1
relative luciferase activity
Gpr124/Reck/Fz1
Fz5
Wnt7a
Gpr124/Reck agonists (25)
Gpr124/Reck/Fz1 signaling
Agonists
Fz5 signaling
NTD
90°
NTD
Linker Linker
CTD CTD
147 Wnt7a single-residue variant positions 90°
Luciferase activity
Fz5 relative luciferase activity
0 31
SP V5
206238266278 349
pCS2
< 10% 10<35% 35<70% > 70%
W322A
E64A
M68A
R222A
T338A
I172A I59A L70A
E72A
F75A
T266AK190A
A58R
K164A
I160A
F162A
P263A
Y260A
R189AI172A
RESEARCH | RESEARCH ARTICLE